Literature DB >> 15033886

Brainstem death testing in the UK--time for reappraisal?

M D D Bell1, E Moss, P G Murphy.   

Abstract

BACKGROUND: A diagnosis of brainstem death in the UK is based on clinical assessment rather than technical investigations, but is considered rigorous enough to be legally synonymous with death.
METHODS: A questionnaire in five sections concerning clinician details, initiation of support, criteria for testing, conduct of the tests, and the process of organ donation, was sent to all members of the Neuroanaesthesia Society.
RESULTS: The survey reveals evidence of failure to apply existing guidelines accurately and a wide variation in practice where the recommendations are not specific.
CONCLUSIONS: In an era of scrutiny of medical process, it is timely to consider whether the current guidelines should be revisited. Clarification of the approach to biochemical derangement, and the role of confirmatory tests when the residual effect of sedative agents cannot be excluded, are two areas worthy of debate.

Entities:  

Mesh:

Year:  2004        PMID: 15033886     DOI: 10.1093/bja/aeh108

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  3 in total

1.  A national multicenter trial on family presence during brain death determination: the FABRA study.

Authors:  Erwin J O Kompanje; Yorick J de Groot; Jan Bakker; Jan N M Ijzermans
Journal:  Neurocrit Care       Date:  2012-10       Impact factor: 3.210

2.  Brain tissue oxygenation in children diagnosed with brain death.

Authors:  Anthony A Figaji; Samuel J Kent
Journal:  Neurocrit Care       Date:  2010-02       Impact factor: 3.210

3.  HUMAN TISSUE LEGISLATION AND MEDICAL PRACTICE: A BENEFIT OR A BURDEN?

Authors:  Sheila A M McLean; Alastair Campbell; Kerry Gutridge; Helen Harper
Journal:  Med Law Int       Date:  2006
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.